Blood biomarkers indicative of Alzheimer's disease (AD) pathology are altered in both
preclinical and symptomatic stages of the disease. Distinctive biomarkers may be optimal for …

Blood biomarkers indicating elevated amyloid-β (Aβ) pathology in preclinical Alzheimer's
disease are needed to facilitate the initial screening process of participants in disease …

Temporal lobe epilepsy is the most common form of focal epilepsy in adults, accounting for
one third of all diagnosed epileptic patients, with seizures originating from or involving …

Introduction This study examines the utility of a multipanel of cerebrospinal fluid (CSF)
biomarkers complementing Alzheimer's disease (AD) biomarkers in a clinical research …

This study investigated differences in retrospective cognitive trajectories between amyloid
and tau PET biomarker stratified groups in initially cognitively unimpaired participants …

Importance Postmenopausal females represent around 70% of all individuals with
Alzheimer disease. Previous literature shows elevated levels of tau in cognitively …

Background and Objectives To investigate the prevalence and trajectories of
neuropsychiatric symptoms (NPS) in relation to cognitive functioning in a cohort of β-amyloid …

Objective To test the hypothesis that neighborhood-level disadvantage is associated with
longitudinal measures of neurodegeneration and cognitive decline in an unimpaired cohort …

Background Walnut consumption counteracts oxidative stress and inflammation, 2 drivers of
cognitive decline. Clinical data concerning effects on cognition are lacking. Objectives The …

Background Current evidence is inconsistent on the benefits of aerobic exercise training for
preventing or attenuating age‐related cognitive decline in older adults. Objective To …